Contrast Media

Contrast media, also called contrast agents, are used to enhance the blood and perfusion in tissues. This includes iodine based contrast for on computed tomography (CT), gadolinium based agents for MRI and lipid bubble contrast agents used in ultrasound.

News | Contrast Media | February 04, 2016
February 4, 2016 — Akrotome Imaging Inc. received a major award from the National Institutes of Health (NIH) in...
Novel MRI Imaging Agent More Effectively Monitors Impact of Treatment in Lung, Prostate Cancers

Molecular imaging of the GRPR biomarker on mice xenografted with PC3 and H441 cells by T1-weighted spin echo MR imaging and NIR imaging.

News | Magnetic Resonance Imaging (MRI) | December 29, 2015
December 29, 2015 — A method to better trace changes in cancers and treatment of the prostate and lung without the...
smart fat cells, liposomes, blood-brain barrier, gliomas, early detection, brain tumors
News | Neuro Imaging | December 22, 2015
December 22, 2015 — A magnetic resonance imaging (MRI) contrast agent that can pass through the blood-brain barrier...
News | Contrast Media | November 29, 2015
November 29, 2015 — Guerbet announced that it has completed its acquisition of the "contrast media and delivery systems...
Access Scientific, Powerwand midline IV catheter, CT contrast injection

Image courtesy of Access Scientific LLC

Technology | Contrast Media | November 02, 2015
November 2, 2015 — Access Scientific LLC announced validation of the Powerwand midline IV catheter for power-injectable...
Lumason, CMS, ultrasound contrast agent, approval for reimbursement
News | Contrast Media | October 21, 2015
October 21, 2015 — Bracco Diagnostics Inc. announced that Lumason was approved by the Centers for Medicare and Medicaid...
Galt Medical, Health Line International Corp., Nexus CT Midline Catheter with MST Insertion Kit

Image courtesy of Galt Medical

Technology | Contrast Media Injectors | October 01, 2015
October 1, 2015 — Galt Medical has partnered with Health Line International Corp. and launched the Nexus CT Midline...
EMI-137, optical imaging agent, detection, early stage, colorectal cancer
News | Oncology Diagnostics | September 18, 2015
September 18, 2015 — Edinburgh Molecular Imaging Ltd. (EM Imaging) has signed an exclusive global license for a novel...
UAMS, Vladimir Zharov, melanoma, theranostics, CTCs, nanoparticles
News | Ultrasound Imaging | September 14, 2015
September 14, 2015 — University of Arkansas for Medical Sciences (UAMS) researcher Vladimir Zharov, Ph.D., D.Sc., was...
ultrasound, microbubbles, delivery, absorption, drugs, pancreatic cancer, ICUS
News | Contrast Media | September 11, 2015
September 11, 2015 — Tiny gas microbubbles can enhance the delivery and absorption of cancer drugs in patients with...
NIH, biomarker, breast cancer, early detection, contrast solution, MRI

Metastasis occurs when cells are shed from primary breast cancer tumor and establish a new tumor at a distant site. For early detection of the metastasis with MRI, the Lu Lab developed a probe that binds to fibrin-fibronectin protein complexes in high-risk tumors. Fibronectin is expressed in high-risk (aggressive) cancer and not in normal tissue, so MRI imaging is able to distinguish metastases from normal tissue. Image courtesy of the National Institutes of Health.

News | MRI Breast | August 12, 2015
August 12, 2015 — Researchers have shown that magnetic resonance imaging (MRI) can detect the earliest signs of breast...
NIR, contrast agents, thyroid, parathyroids, surgery, Frangioni, FLARE

Intraoperative image of thyroid (red) and parathyroids (green) in rats four hours after intravenous injection of targeted contrast agents. Image captured using the FLARE system. Image courtesy of Macmillan Publishers Ltd.

News | Contrast Media | July 29, 2015
July 29, 2015 — Researchers funded by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) have...
Guerbet, acquisition, Mallinckrodt, CMDS business, contrast media, CT, MRI
Feature | Contrast Media | July 28, 2015
July 28, 2015 — Guerbet announced that it has entered into a definitive agreement under which it will acquire...
MRI, gadolinium, contrast agents, Wolters Kluwer, safety issue
Feature | Contrast Media | June 26, 2015
June 26, 2015 - New results in animals highlight a major safety concern regarding a class of magnetic resonance imaging...
molecular MRI, contrast agents, PSMA, cancer, SNMMI, Sangeeta Ray
News | June 16, 2015
June 16, 2015 - The prostate-specific membrane antigen (PSMA) biomarker is the bullseye for three new magnetic...
Bracco, Lumason, first U.S. echocardiography procedure, Morristown
Feature | Contrast Media | June 04, 2015
June 4, 2015 - Bracco Imaging announced that the first echocardiography imaging procedure with Lumason was performed in...
Visipaque, IOCM, LOCM, angioplasty, EuroPCR 2015
News | May 22, 2015
May 22, 2015 — Significantly fewer renal and cardiac events are associated with angioplasty procedures using isosmolar...
gadolinium, brain, contrast MRI, Radiology, Kanal, brain, brain MRI with contrast
Feature | May 05, 2015
May 5, 2015 — New research, published in the journal Radiology, suggests some types of a popular contrast agent used in...
Technology | March 06, 2015
March 6, 2015 — Bracco Imaging, through its business unit Bracco Injeneering SA, announced the availability of its...
nanoparticles, stroke, tPA, blood clot, magnetic, MRI, antiplatelet

Each nanoparticle is composed of an iron oxide core (red squares) that is swathed in albumin (grey) and the anti-clotting agent tPA (green). The iron oxide cubes are about 20 nm on a side.

News | February 26, 2015
February 26, 2015 — By loading magnetic nanoparticles with drugs and dressing them in biochemical camouflage, Houston...